Patent 7569337 was granted and assigned to Novartis on August, 2009 by the United States Patent and Trademark Office.
The invention provides compounds of formula (I), wherein R, R1, R2, R3 and R4 are as defined in the description, and their preparation. The compounds of formula I are useful as biomarkers.